E-LIB Suche - Ergebnisse für: Brar, Satjit

1

Pharmacokinetic and Pharmacologic Characterization of the D..:

Brar, Satjit ; Vijan, Arjun ; Scott, Fiona L....
Clinical Pharmacology in Drug Development. 12 (2022) 4 - p. 447-456 , 2022

Link: https://doi.org/10.1002/..

2

Model‐informed drug development supporting the approval of ..:

Masters, Joanna C. ; Khandelwal, Akash ; di Pietro, Alessandra..
CPT: Pharmacometrics & Systems Pharmacology. 11 (2022) 4 - p. 458-468 , 2022

Link: https://doi.org/10.1002/..

3

A Model-Informed Drug Development Approach Supporting the A..:

Nguyen, Hoa Q. ; Kuan, H. Steve ; Crass, Ryan L....
CNS Spectrums. 27 (2022) 2 - p. 238-238 , 2022

Link: https://doi.org/10.1017/..

4

Industrial Perspective on the Benefits Realized From the FD..:

Galluppi, Gerald R. ; Brar, Satjit ; Caro, Luzelena...
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1172-1175 , 2021

Link: https://doi.org/10.1002/..

5

Avelumab in relapsed/refractory classical Hodgkin lymphoma:..:

Herrera, Alex F. ; Burton, Catherine ; Radford, John...
Blood Advances. 5 (2021) 17 - p. 3387-3396 , 2021

Link: https://doi.org/10.1182/..

6

Changing Body Weight–Based Dosing to a Flat Dose for Avelum..:

Novakovic, Ana M. ; Wilkins, Justin J. ; Dai, Haiqing...
Clinical Pharmacology & Therapeutics. 107 (2019) 3 - p. 588-596 , 2019

Link: https://doi.org/10.1002/..

7

Time‐Varying Clearance and Impact of Disease State on the P..:

Wilkins, Justin J. ; Brockhaus, Brigitte ; Dai, Haiqing...
CPT: Pharmacometrics & Systems Pharmacology. 8 (2019) 6 - p. 415-427 , 2019

Link: https://doi.org/10.1002/..

8

Clinical Trials in Pulmonary Hypertension: Time for a Conso..:

Newman, John H. ; Elliott, Gregory C. ; Haworth, Glennis S....
Pulmonary Circulation. 3 (2013) 1 - p. 245-251 , 2013

Link: https://doi.org/10.4103/..

9

Impact of Pharmacometric Analyses on New Drug Approval and ..:

Lee, Joo Yeon ; Garnett, Christine E. ; Gobburu, Jogarao V.S....
Clinical Pharmacokinetics. 50 (2011) 10 - p. 627-635 , 2011

Link: https://doi.org/10.2165/..

10

To Take or Not to Take With Meals? Unraveling Issues Relate..:

Deng, Jiexin ; Brar, Satjit S. ; Lesko, Lawrence J.
Clinical Pharmacology in Drug Development. 7 (2017) 5 - p. 455-464 , 2017

Link: https://doi.org/10.1002/..

11

Avelumab in relapsed/refractory classical Hodgkin lymphoma:..:

Herrera, Alex F ; Burton, Catherine ; Radford, John...
Herrera , A F , Burton , C , Radford , J , Miall , F , Townsend , W , Santoro , A , Zinzani , P L , Lewis , D , Fowst , C , Brar , S , Huang , B , Thall , A & Collins , G P 2021 , ' Avelumab in relapsed/refractory classical Hodgkin lymphoma : phase 1b results from the JAVELIN Hodgkins trial ' , Blood Advances , vol. 5 , no. 17 , pp. 3387-3396 . https://doi.org/10.1182/BLOODADVANCES.2021004511. , 2021

Link: https://research.manches..

12

Industrial Perspective on the Benefits Realized From the FD..:

Galluppi, Gerald R ; Brar, Satjit ; Caro, Luzelena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596613/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Avelumab in relapsed/refractory classical Hodgkin lymphoma:..:

Herrera, Alex F ; Burton, Catherine ; Radford, John...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525219/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Time‐Varying Clearance and Impact of Disease State on the P..:

Wilkins, Justin J ; Brockhaus, Brigitte ; Dai, Haiqing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617853/. , 2019

Link: http://www.ncbi.nlm.nih...

15

Changing Body Weight–Based Dosing to a Flat Dose for Avelum..:

Novakovic, Ana M ; Wilkins, Justin J ; Dai, Haiqing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027979/. , 2019

Link: http://www.ncbi.nlm.nih...